What Otava Chemicals does

Otava Chemicals (legal entities OTAVA CHEMICALS MB in Vilnius, Lithuania and OTAVA LTD. in Vaughan, Canada; doing business as OTAVAchemicals) is a privately held specialty chemical supplier that develops, produces, and distributes synthetic organic compounds, biochemicals, and bioanalytical reagents for pharmaceutical, biotechnology, academic, and agrochemical research customers. The company was founded in 1997 and operates a catalog spanning chemical building blocks, fragment libraries, high-throughput screening collections, targeted and disease-focused libraries (including AI-powered libraries for GLP-1R, GPCR, RNA-binding, and HDAC1/mTOR), biochemical inhibitors, fluorescent dyes, quaternary ammonium salts, and kilo-scale compounds.

Its two flagship platforms are CHEMriya, an ultra-large combinatorial virtual chemical space of 55+ billion synthetically feasible small molecules used for hit expansion, hit-to-lead optimization, and compound evolution, and ChemInfinita, an 800+ billion make-on-demand virtual compound collection built with Alipheron for beyond-Rule-of-5 drug discovery. Both spaces are exposed to end users through third-party discovery platforms including BioSolveIT, CHEESE Search, CHEESE SynthonGPT (Deep MedChem), Alipheron Hyperspace Search, and Pharos-3D.

Otava generates revenue from one-time catalog compound sales priced per milligram in EUR, custom synthesis and contract research services quoted on request, and library sales to pharma and biotech screening programs. Distribution combines a self-serve online compound search, direct regional sales representatives, and three major catalog partners — Sigma-Aldrich (vendor no: 1028218), Fisher Scientific (VN00088530), and VWR International (13807) — providing reach across North America, Europe, and the broader global research market. All compounds are sold for research use only under the research exemption provisions of patent law in the US, Japan, Germany, the UK, Canada, and New Zealand.

Name

Otava Chemicals

Legal name

OTAVA CHEMICALS MB / OTAVA LTD.

Website

https://otavachemicals.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

Otava Chemicals supplies synthetic organic compounds, biochemicals, and bioanalytical reagents for drug discovery, operating the CHEMriya (55+ billion) and ChemInfinita (800+ billion) virtual chemical spaces, plus custom synthesis and contract research, sold direct and through Sigma-Aldrich, Fisher Scientific, and VWR to pharma, biotech, academic, and agrochemical researchers.

Ownership category

akta.pro rank

Product category

Drug Discovery Research Chemicals

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Chiral / Asymmetric Synthesis & Complex Chemistry Services (HLAGAHAE)

Keywords

• Synthetic organic compounds
• Compound library screening
• Drug discovery reagents
• Chemical building blocks
• Virtual chemical space

Headquarters

HQ city

Vilnius

HQ country

Lithuania

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Chemical Compound Sales: Sale of synthetic organic compounds including building blocks, fragment libraries, screening compounds, targeted libraries, and biochemical inhibitors. Compounds available in milligram and gram quantities with pricing per mg.
2. Custom Synthesis Services: Custom synthesis of compounds based on customer-provided structures. Customers send single or multiple structures as attached files (.cdx, .skc, .mol, .sdf formats) for quote.
3. Compound Library Sales: Pre-designed and custom-targeted compound libraries sold to pharmaceutical and biotech companies for drug discovery screening programs

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Core offering

Otava Chemicals develops and supplies synthetic organic compounds, biochemicals, and bioanalytical reagents for pharmaceutical research and drug discovery. Its portfolio centers on two proprietary virtual compound platforms - CHEMRIYA (55+ billion molecules) and ChemInfinita (800+ billion make-on-demand compounds) - together with physical chemical building blocks, fragment libraries, HTS screening collections, targeted libraries, and custom synthesis, route optimization, and computational chemistry services. Products are sold in milligram to kilogram quantities for research use only.

Product overview

OTAVAchemicals is a synthetic organic compounds supplier for research and drug discovery, offering a comprehensive portfolio centered around two core virtual compound platforms: CHEMriya (55+ billion molecules) and ChemInfinita (800+ billion make-on-demand compounds). The product portfolio includes Chemical Building Blocks, Fragment Libraries (General, Solubility, Fluorine, Chelator, Halogen-Enriched, SuFEx Handle), Compounds for HTS (Diversity, Screening Collections, Lead-Like, CNS, Natural Product-Like), and extensive Targeted Libraries (SARS-CoV-2, Protein-Protein Interaction, AI-powered GLP-1R/GPCR/RNA-Binding/HDAC1/mTOR libraries, Disease-Based for Alzheimer's/Diabetes/Cancer/Hepatitis C, Covalent Inhibitors, CELMoDs, kinase/protease/GPCR/nuclear receptor/ion channel libraries). Supporting services include Custom Synthesis, Chemical Route Optimization, SAVI, Molecular Modeling, Bioinformatics, Contract Research, and the Seed Innovation Discovery Program. Products are distributed through Sigma-Aldrich, Fisher Scientific, and VWR International.

Differentiator

Problem solved

Functional benefit

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability7 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core, important and major.

• Deep MedChemcoreTechnology or IntegrationIntegration of ChemInfinita (800+ billion make-on-demand compounds) into CHEESE SynthonGPT, the AI-driven synthesis-aware discovery platform developed by Deep MedChem. This enables researchers to explore virtual chemical space within a generative, synthesis-constrained search environment.
• AlipheroncoreTechnology or IntegrationCollaboration to build ChemInfinita virtual chemical space from commercial and proprietary building blocks and lab-validated reaction templates. ChemInfinita is searchable through Alipheron's Hyperspace Search and Pharos-3D platforms.
• Melius OrganicsimportantStrategic or Co-development PartnerCollaboration to develop the SuFEx Handle Fragment Library - a comprehensive collection of aryl fluorosulfates and sulfamoyl fluorides designed for next-generation covalent drug discovery and chemical synthesis.
• Sigma-AldrichmajorChannel Partner/ Reseller/ DistributorDistribution partner for Otava Chemicals products. Vendor number: 1028218. Enables broad market reach through Sigma-Aldrich's established distribution network.
• Fisher ScientificmajorChannel Partner/ Reseller/ DistributorDistribution partner for Otava Chemicals products. Vendor number: VN00088530. Extends product availability through Fisher Scientific's laboratory supply channels.
• VWR InternationalmajorChannel Partner/ Reseller/ DistributorDistribution partner for Otava Chemicals products. Vendor number: 13807. Provides additional distribution channel through VWR's laboratory supply network.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Life Chemicals: Life Chemicals designs and sells focused screening libraries, building blocks, and custom synthesis services for pharma R&D, making it a direct peer in targeted libraries and HTS collections.
• ChemSpace: ChemSpace is a marketplace and supplier of chemical building blocks and screening compounds for drug discovery — a similar SMB-scale peer with overlapping catalog and online ordering model.
• Enamine: Enamine is the largest dedicated supplier of building blocks and screening compounds globally and runs the REAL Database of synthetically accessible compounds — the closest direct competitor to Otava's CHEMriya and ChemInfinita offerings for pharma and biotech drug discovery.
• ChemDiv: ChemDiv provides screening libraries, building blocks, and custom synthesis services to pharma and biotech — overlapping head-to-head with Otava's HTS collections, targeted libraries, and Custom Synthesis offering.
• MolPort: MolPort operates a compound sourcing marketplace and integrated chemical building block database — a direct competitor to Otava's online compound search and aggregated supplier model.
• Combi-Blocks: Combi-Blocks supplies screening compound libraries and custom synthesis for drug discovery, directly overlapping Otava's building blocks, focused libraries, and custom synthesis services.
• BioAscent: BioAscent provides drug discovery services including compound management, custom synthesis, and library design — directly comparable to Otava's contract research, custom synthesis, and targeted library offerings.

Broad incumbents

• WuXi AppTec: WuXi AppTec is a global CRO/CDMO with extensive chemistry services and compound libraries; it is a broad incumbent whose research chemistry services and catalog overlap with Otava's custom synthesis and library offerings at much greater scale.
• Charles River Laboratories: Charles River offers discovery and safety services including chemistry support and custom synthesis — a large incumbent whose early-stage discovery portfolio overlaps with Otava's CRO/contract research services.
• Sigma-Aldrich (Merck KGaA / MilliporeSigma): Sigma-Aldrich is both Otava's distribution partner and a competitor, selling its own research chemicals, building blocks, and screening collections — a broad incumbent whose catalog overlaps significantly with Otava's product range.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Otava Chemicals